1. Home
  2. BV vs IMTX Comparison

BV vs IMTX Comparison

Compare BV & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BV

BrightView Holdings Inc.

HOLD

Current Price

$12.80

Market Cap

1.2B

ML Signal

HOLD

Logo Immatics N.V.

IMTX

Immatics N.V.

HOLD

Current Price

$10.07

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BV
IMTX
Founded
1939
N/A
Country
United States
Germany
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.3B
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
BV
IMTX
Price
$12.80
$10.07
Analyst Decision
Hold
Strong Buy
Analyst Count
4
5
Target Price
$14.63
$19.25
AVG Volume (30 Days)
654.8K
564.1K
Earning Date
02-04-2026
11-17-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.13
N/A
Revenue
$2,672,800,000.00
$99,445,031.00
Revenue This Year
$3.75
N/A
Revenue Next Year
$2.81
$19.39
P/E Ratio
$98.92
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.06
$3.30
52 Week High
$17.11
$12.41

Technical Indicators

Market Signals
Indicator
BV
IMTX
Relative Strength Index (RSI) 53.26 48.56
Support Level $12.64 $9.96
Resistance Level $13.05 $10.50
Average True Range (ATR) 0.27 0.42
MACD 0.01 -0.02
Stochastic Oscillator 62.44 49.50

Price Performance

Historical Comparison
BV
IMTX

About BV BrightView Holdings Inc.

BrightView Holdings Inc is a provider of commercial landscaping services in the United States. The company provides commercial landscaping services, landscape maintenance, and enhancements to tree care and landscape development. It operates through two segments namely Maintenance Services, and Development Services. The Maintenance Services are self-performed through a national branch network and are route-based in nature. It includes mowing, gardening, mulching and snow removal, water management etc. And Development Services are comprised of sophisticated design, coordination, and installation of landscapes at recognizable corporate, athletic, and university complexes. The company generates a majority of its revenue from Maintenance Services.

About IMTX Immatics N.V.

Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.

Share on Social Networks: